The GPR40 novel agonist SZZ15 ‐11 improves non‐alcoholic fatty liver disease by activating the AMPK pathway and restores metabolic homeostasis in diet‐induced obese mice

Ähnliche Einträge

• Oleuropein mitigates non‐alcoholic fatty liver disease (NAFLD) and modulates liver metabolites in high‐fat diet‐induced obese mice via activating PPARα
  von: Wei Zhou, et al.
  Veröffentlicht: (2024)
• Medium‐chain fatty acid receptor GPR84 deficiency leads to metabolic homeostasis dysfunction in mice fed high‐fat diet
  von: Akari Nishida, et al.
  Veröffentlicht: (2024)
• Paternal preconceptional supplementation of n‐3 polyunsaturated fatty acids alleviates offspring nonalcoholic fatty liver disease in high‐fat diet‐induced obese mice
  von: Qiaoyu Shi, et al.
  Veröffentlicht: (2024)
• Copper homeostasis and cuproptosis‐related genes: Therapeutic perspectives in non‐alcoholic fatty liver disease
  von: Wangjing Tan, et al.
  Veröffentlicht: (2024)
• Ethyl acetate fraction of oregano seed protects non‐alcoholic fatty liver in high‐fat diet‐induced obese mice through modulation of Srebp‐1c
  von: Hyun‐Jong Lee, et al.
  Veröffentlicht: (2024)